Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 November 2022 | Story Gerda-Marié van Rooyen
Antjie Krog at UFS
The award-winning writer, Antjie Krog, will be the keynote speaker at the International Hybrid Conference from 24 to 26 November 2022. This conference is a joint venture of the University of the Free State (UFS) Centre for Gender and Africa Studies and the War Museum.

The award-winning writer, Antjie Krog, will be the keynote speaker later this week at an International Hybrid Conference titled, The Unsung Heroines and Youth of South Africa: Violent Histories and Experiences of South African Women and Children during Wars, Conflicts and Pandemics. This conference – a joint project of the Centre for Gender and Africa Studies at the University of the Free State (UFS) and the War Museum – starts on Thursday 24 November and will be hosted at the War Museum in Bloemfontein and broadcast online. The three-day conference overlaps with the global 16 Days of Activism Against Gender-Based Violence and aims to assemble historians, academics, and other scholars researching the violent histories of not only women and children in the South African War but in other wars, conflicts, and pandemics as well.

Prof Krog, an Extraordinary Professor in the Faculty of Arts at the University of the Western Cape, poet, and author of Country of my Skull (among other books), is an alumna of the UFS, where she completed a BA degree with Afrikaans, Philosophy, and English. She will deliver her keynote address, Survival, Complicity, and Race: (Im)possibilities of Narrating and Interpreting Rape in Havenga Affidavits, on the first day of the conference.

Prof Heidi Hudson, Dean of the Faculty of the Humanities at the UFS, will deliver her keynote address on Friday (25 November 2022). Prof Hudson is considered a specialist in feminist security studies. Her keynote address is titled Disciplinary and other stories: From women’s peace movements to the Women, Peace and Security ecosystem.

Several historians, academics, and scholars will either present their research or attend the conference. The conference aims to gather various stakeholders who are researching the violent histories of not only the women and children in the South African War, but other wars, conflicts, and pandemics in South African history dating from precolonial times to the World Wars, Apartheid, to the present. Each of the eight sessions over the first two days will conclude with time set aside for discussion.

The conference programme includes a visit to the art exhibition Unsung Heroes at the Oliewenhuis Art Museum on Friday after the last session. On Saturday, conference attendees can look forward to a tour of Bloemfontein. Click here for more information or send an email to vicky@anglo-boer.co.za.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept